OS Therapies Incorporated

OSTXAMEX • USD
0.68 USD
↘ 0.00 (0.10%)🟢PRE MARKET (AS OF 04:15 AM EST)
🟢Market: OPEN

OS Therapies Incorporated (OSTX) is currently trading at $0.68. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (330.4%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Nov 16, 2026.

Open?$0.68
High?$0.68
Low?$0.68
Prev. Close?$0.68
Volume?2
Avg. Volume?799.1K
VWAP?$0.68
Rel. Volume?0.00x
Bid / Ask
Bid?$0.68 × 200
Ask?$0.70 × 400
Spread?$0.02
Midpoint?$0.69
Valuation & Ratios
Market Cap?31.8M
Shares Out?4.6M
Float?4.1M
Float %?89.6%
P/E Ratio?N/A
P/B Ratio?-2.67
EPS?-$0.84
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The company's mission is to address the need for new treatments in cancers of the bone in children and young adults. The company has pipeline of product candidates targeting multiple indications for solid cancers including two drug technologies: (i) OST-HER2, an off-the-shelf immunotherapy, which is a type of cancer treatment that helps the immune system fight cancer and OST-tADC which is a tunable drug conjugate (tADC) platform currently in preclinical development. Each tADC contains four main components: ligand, payload cassette adaptor, linker and payload.
Employees
5
Market Cap
34.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2024-08-01
Address
15825 SHADY GROVE ROAD
ROCKVILLE, MD 20850
Phone: 410-297-7793
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
16
Piotroski F-Score?0/9Weak
Altman Z-Score?-25.88Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?67.05%Squeeze Risk
Short Interest?2.8M
Days to Cover?7.7
Free Float4.1M
Avg Daily Volume357.2K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.18Weak
Quick Ratio?0.18Weak
Cash Ratio?0.01Low
Debt/Equity?-0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-2.67CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
330.4%STRONG▾
ROA?
S&P
3
-397.8%WEAK▾
Cash Flow & Enterprise
FCF?$-18532848
Enterprise Value?$31.7M
Fundamentals ratios updated end of day